Pharma Journalist -

Verge Genomics, a biotech company that has created an industry leading all-in-human, artificial-intelligence-powered drug discovery and development platform focused on therapies for…
Read More...

INBRAIN Neuroelectronics, a company at the intersection of medtech, deeptech and digital health dedicated to developing the world’s first graphene-based intelligent neuroelectronic…
Read More...

LGM Pharma announced the launch of its new Analytical Services offering that provides analytical testing and stability services to pharmaceutical developers and manufacturers, including…
Read More...

Funding from the COVID-19 Therapeutics Accelerator to advance Exscientia’s novel class of AI-designed coronavirus SARS-CoV-2 Mpro inhibitors to development candidates OXFORD, U.K. --…
Read More...

Sequanta Technologies Co., Ltd. and Mission Bio. are pleased to announce that they have entered into a strategic partnership, providing high-quality single-cell sequence services using…
Read More...

SRI International (SRI) announced that the company has entered a research collaboration with Sanofi. By leveraging SRI’s SynFini platform, an artificial intelligence (AI)-guided,…
Read More...

For gene therapy developers seeking to rapidly and efficiently scale production, a set of solutions is now available from Thermo Fisher Scientific to support adeno-associated viral…
Read More...

United States Pharmacopeia (USP), an independent, scientific nonprofit organization, is pleased to announce the acquisition of Pharmatech Associates, Inc. By adding Pharmatech…
Read More...

Vaxart, Inc. a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced that it has signed an…
Read More...

Algernon Pharmaceuticals Inc. a clinical stage pharmaceutical development company, announces that it has reached 70% of its enrollment target for its Phase 2 clinical study of its…
Read More...